ICARES Medicus, Inc. (TPEX:6612)
Taiwan · Delayed Price · Currency is TWD 67.20
-5.90 (-8.07%)
At close: Feb 11, 2026
ICARES Medicus Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 63.38 | 103.12 | 97.73 | 128.91 | 58.6 | 51.91 |
Depreciation & Amortization | 137.41 | 87.52 | 42.66 | 26.56 | 27.16 | 28.44 |
Other Amortization | 4.19 | 1.53 | 1.08 | 1.75 | 1.54 | 1.6 |
Loss (Gain) From Sale of Assets | -0.92 | - | - | - | - | -4.02 |
Loss (Gain) From Sale of Investments | 12.39 | 0.38 | -8.87 | -4.67 | 13.12 | - |
Loss (Gain) on Equity Investments | -8.39 | -2.38 | 1.35 | 4.18 | 2.17 | 5.46 |
Stock-Based Compensation | 15.19 | 27.39 | 20.13 | 9.79 | 11.13 | 5.45 |
Provision & Write-off of Bad Debts | 0.8 | 5.81 | 10.08 | 2.43 | 3.16 | -1.21 |
Other Operating Activities | -75.15 | -10.14 | -38.05 | -24.64 | -29.33 | -23.46 |
Change in Accounts Receivable | -42 | -11.49 | -33.28 | -45.69 | -28.04 | 27.19 |
Change in Inventory | -117.41 | -115.21 | -50.33 | -20.82 | -9.49 | -0.9 |
Change in Accounts Payable | -12.73 | -19.74 | -1.76 | 3.67 | 0.89 | -2.15 |
Change in Unearned Revenue | 13.01 | -7.55 | 5.31 | - | - | - |
Change in Other Net Operating Assets | 35.69 | -70.05 | -71.83 | 47.44 | -12.33 | -16.95 |
Operating Cash Flow | 25.45 | -10.82 | -25.79 | 128.92 | 38.57 | 71.37 |
Operating Cash Flow Growth | - | - | - | 234.27% | -45.96% | -19.61% |
Capital Expenditures | -137.98 | -148.97 | -70.95 | -31.45 | -5.39 | -9.11 |
Sale of Property, Plant & Equipment | 0.1 | 1.39 | - | - | 0.01 | 32.48 |
Cash Acquisitions | -688.43 | -688.43 | - | - | - | -47.97 |
Sale (Purchase) of Intangibles | -6.88 | -7.75 | -5.52 | -2.59 | -1.09 | -2.08 |
Investment in Securities | 309.65 | 293.32 | -449.46 | -167.07 | - | -60.38 |
Other Investing Activities | 358.68 | -0.16 | -1.65 | -1.45 | -0.13 | -12.3 |
Investing Cash Flow | -164.86 | -550.6 | -527.58 | -202.56 | -6.6 | -99.36 |
Short-Term Debt Issued | - | 316.32 | 21.49 | - | - | - |
Long-Term Debt Issued | - | 505.44 | - | - | - | - |
Total Debt Issued | 365.43 | 821.75 | 21.49 | - | - | - |
Short-Term Debt Repaid | - | -22.52 | - | - | - | - |
Long-Term Debt Repaid | - | -177.99 | -18.03 | -8.29 | -8.12 | -6.78 |
Total Debt Repaid | -337.14 | -200.51 | -18.03 | -8.29 | -8.12 | -6.78 |
Net Debt Issued (Repaid) | 28.29 | 621.25 | 3.46 | -8.29 | -8.12 | -6.78 |
Issuance of Common Stock | 59.71 | - | 598.43 | - | - | - |
Common Dividends Paid | -12.92 | -7.83 | -34.16 | -16.99 | -3.4 | -16.87 |
Other Financing Activities | 134.1 | -0.94 | 88.37 | 1.38 | 58.09 | 29.33 |
Financing Cash Flow | 209.18 | 612.48 | 656.1 | -23.89 | 46.57 | 5.69 |
Foreign Exchange Rate Adjustments | -35.39 | 7.47 | -6.05 | 25.86 | -3.62 | -6.82 |
Net Cash Flow | 34.38 | 58.52 | 96.67 | -71.67 | 74.92 | -29.11 |
Free Cash Flow | -112.53 | -159.8 | -96.74 | 97.47 | 33.18 | 62.26 |
Free Cash Flow Growth | - | - | - | 193.75% | -46.70% | - |
Free Cash Flow Margin | -10.35% | -18.59% | -15.98% | 19.04% | 8.42% | 17.17% |
Free Cash Flow Per Share | -2.39 | -3.38 | -2.28 | 2.37 | 0.81 | 1.53 |
Cash Interest Paid | 28.22 | 17.86 | 6.79 | 0.35 | 0.62 | 0.75 |
Cash Income Tax Paid | 94.54 | 72.17 | 54.77 | 40.74 | 42.44 | 45.32 |
Levered Free Cash Flow | -150.54 | -286.65 | -43.38 | 10.56 | 96.64 | 51.52 |
Unlevered Free Cash Flow | -135.51 | -275.19 | -38.89 | 10.92 | 97.16 | 52.13 |
Change in Working Capital | -123.46 | -224.04 | -151.89 | -15.4 | -48.98 | 7.19 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.